Search Results

There are 52264 results for: content related to: Does antidepressant medication use affect persistence with diabetes medicines?

  1. Development of a mother–child database for drug exposure and adverse event detection in the Military Health System

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 5, May 2015, Pages: 510–517, Lockwood G. Taylor, Rosenie Thelus Jean, Geoff Gordon, David Fram and Trinka Coster

    Article first published online : 31 MAR 2015, DOI: 10.1002/pds.3759

  2. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  3. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Article first published online : 24 FEB 2014, DOI: 10.1002/pds.3596

  4. Antidepressant use, serotonin transporter affinity, and reinfarction among patients receiving clopidogrel: a population-based study

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 12, December 2012, Pages: 1328–1333, Naif Fnais, Mashael Alshaikh, Zhan Yao, Tara Gomes, David Juurlink and Muhammad Mamdani

    Article first published online : 22 OCT 2012, DOI: 10.1002/pds.3358

  5. Antidepressant therapy in cancer patients: initiation and factors associated with treatment

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 6, June 2015, Pages: 600–609, Sallie-Anne Pearson, Michal Abrahamowicz, Preeyaporn Srasuebkul and Nicholas Allan Buckley

    Article first published online : 8 APR 2015, DOI: 10.1002/pds.3753

  6. First-trimester exposure to bupropion and risk of cardiac malformations

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 10, October 2014, Pages: 1066–1075, Carol Louik, Stephen Kerr and Allen A. Mitchell

    Article first published online : 12 JUN 2014, DOI: 10.1002/pds.3661

  7. You have free access to this content
    A systematic review of validated methods for identifying depression using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 163–173, Lisa Townsend, James T Walkup, Stephen Crystal and Mark Olfson

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2310

  8. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1205–1212, David J. Graham, Kunthel By, Stephen McKean, Andrew Mosholder, Cynthia Kornegay, Judith A. Racoosin, Jessica Young, Mark Levenson, Thomas E. MaCurdy, Chris Worrall and Jeffrey A. Kelman

    Article first published online : 5 JUL 2014, DOI: 10.1002/pds.3678

  9. Identifying suicidal behavior among adolescents using administrative claims data

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 769–775, S. Todd Callahan, D. Catherine Fuchs, Richard C. Shelton, Leanne S. Balmer, Judith A. Dudley, Patricia S. Gideon, Michelle M. DeRanieri, Shannon M. Stratton, Candice L. Williams, Wayne A. Ray and William O. Cooper

    Article first published online : 15 FEB 2013, DOI: 10.1002/pds.3421

  10. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 12, December 2013, Pages: 1336–1344, Miriam P. O'Shea, Mary Teeling and Kathleen Bennett

    Article first published online : 21 OCT 2013, DOI: 10.1002/pds.3535

  11. Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue S1, August 2011, Pages: S1–S364,

    Article first published online : 12 AUG 2011, DOI: 10.1002/pds.2206

  12. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  13. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Article first published online : 25 NOV 2015, DOI: 10.1002/pds.3912

  14. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Article first published online : 24 JUN 2015, DOI: 10.1002/pds.3820

  15. Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 8, August 2014, Pages: 830–838, Krista F. Huybrechts, Tobias Gerhard, Jessica M. Franklin, Raisa Levin, Stephen Crystal and Sebastian Schneeweiss

    Article first published online : 24 MAR 2014, DOI: 10.1002/pds.3611

  16. Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 934–942, Sonja A. Swanson, Sonia Hernandez-Diaz, Kristin Palmsten, Helen Mogun, Mark Olfson and Krista F. Huybrechts

    Article first published online : 4 JUN 2015, DOI: 10.1002/pds.3798

  17. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Article first published online : 10 MAR 2014, DOI: 10.1002/pds.3592

  18. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1222–1232, Carlos Iribarren, Alfred D. Round, Jonathan A. Peng, Meng Lu, Jonathan G. Zaroff, Taylor J. Holve, Amit Prasad and Paul Stang

    Article first published online : 16 JUL 2013, DOI: 10.1002/pds.3479

  19. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 980–988, Chi-Shin Wu, Wen-Yi Shau, Hung-Yu Chan, Yen-Chieh Lee, Yun-Ju Lai and Mei-Shu Lai

    Article first published online : 17 APR 2012, DOI: 10.1002/pds.3255

  20. Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 972–979, Falk Hoffmann, Gerd Glaeske, Franz Petermann and Christian J. Bachmann

    Article first published online : 28 MAY 2012, DOI: 10.1002/pds.3295